Register now and you will receive a link for the event
June 22, 2021 From 1:00 – 2:00 pm EDT
Join our panel of experts for presentations and discussion on drug development and outcome measures in eosinophilic esophagitis (EoE)
Swallowed topical corticosteroids and proton pump inhibitors have historically been the mainstays of medical therapy for EoE. Several new classes of treatment are now in development and the therapeutic landscape is anticipated to change drastically over the next decade.
Presentations from our experts will span basic science to clinical trials covering topics including:
Dr. Albert J (Arjan) Bredenoord studied Medicine in Antwerp, Belgium. He subsequently worked on several… Read More
Evan S. Dellon, MD, MPH, is a Professor of Medicine and Adjunct Professor of Epidemiology at the University of North… Read More
The objective of her research is to study outcome assessment in adults with eosinophilic esophagitis (EoE)… Read More